- Home
- XERS vs STKL Comparison
XERS vs STKL Comparison
Compare XERS & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- STKL
- Stock Information
- Founded
- XERS 2005
- STKL 1973
- Country
- XERS United States
- STKL United States
- Employees
- XERS 394
- STKL N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- STKL Precious Metals
- Sector
- XERS Health Care
- STKL Basic Materials
- Exchange
- XERS Nasdaq
- STKL Nasdaq
- Market Cap
- XERS 1.3B
- STKL 644.1M
- IPO Year
- XERS 2018
- STKL N/A
- Fundamental
- Price
- XERS $7.93
- STKL $6.31
- Analyst Decision
- XERS Strong Buy
- STKL Strong Buy
- Analyst Count
- XERS 7
- STKL 2
- Target Price
- XERS $8.00
- STKL $9.50
- AVG Volume (30 Days)
- XERS 3.5M
- STKL 902.2K
- Earning Date
- XERS 08-07-2025
- STKL 08-06-2025
- Dividend Yield
- XERS N/A
- STKL N/A
- EPS Growth
- XERS N/A
- STKL N/A
- EPS
- XERS N/A
- STKL N/A
- Revenue
- XERS $246,025,000.00
- STKL $762,882,000.00
- Revenue This Year
- XERS $43.89
- STKL $10.94
- Revenue Next Year
- XERS $20.40
- STKL $8.49
- P/E Ratio
- XERS N/A
- STKL N/A
- Revenue Growth
- XERS 35.62
- STKL 11.44
- 52 Week Low
- XERS $2.48
- STKL $3.65
- 52 Week High
- XERS $8.02
- STKL $8.11
- Technical
- Relative Strength Index (RSI)
- XERS 80.36
- STKL 55.81
- Support Level
- XERS $7.27
- STKL $6.24
- Resistance Level
- XERS $8.02
- STKL $6.52
- Average True Range (ATR)
- XERS 0.32
- STKL 0.20
- MACD
- XERS 0.03
- STKL 0.03
- Stochastic Oscillator
- XERS 93.99
- STKL 72.22
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About STKL SunOpta Inc.
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.